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ABSTRACT 
 
Eukaryotic initiation factor 2 (eIF2), a heterotrimeric GTPase, has a central role in protein 
biosynthesis by supplying methionylated initiator tRNA to the ribosomal translation initiation complex 
and by serving as a target for translational control in response to stress. Recent work identified a novel 
step indispensable for eIF2 function: assembly of eIF2 from its three protein subunits by the cell 
proliferation protein Cdc123. We report the first crystal structure of a Cdc123 representative, that from 
Schizosaccharomyces pombe, both isolated and bound to the domain III of eIF2γ from Saccharomyces 
cerevisiae. The structures show that Cdc123 resembles enzymes of the ATP-grasp family. Indeed, 
Cdc123 binds ATP-Mg2+ and conserved residues contacting ATP-Mg2+ are essential for Cdc123 to 
support eIF2 assembly and cell viability. A docking of eIF2αγ onto Cdc123, combined with genetic 
and biochemical experiments, allows us to propose a model explaining how Cdc123 participates in the 
biogenesis of eIF2 through facilitating assembly of eIF2γ to eIF2α.  
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INTRODUCTION 
Initiation of the translation of a messenger RNA into a protein involves a complex cascade of 
molecular events, leading to a translation-competent ribosome with a methionylated initiator tRNA in 
the P-site, base-paired with the start codon on mRNA (Hinnebusch, 2011; Lorsch and Dever, 2010). A 
critical consequence of the whole process is the setting of the reading frame for mRNA decoding. In 
eukaryotic and archaeal cells, the initiator tRNA carrier is the e/aIF2 heterotrimer. e/aIF2 results from 
the association of three subunits, α, β and γ. The γ subunit forms the core of the heterotrimer. It 
interacts with both the α and the β subunits while α and β do not interact together (Schmitt et al., 
2010). In its GTP-bound form, this factor specifically binds Met-tRNAiMet (Schmitt et al., 2012) and 
handles it in the initiation complex (Huang et al., 1997). After start codon recognition, the factor, in its 
GDP-bound form, loses affinity for Met-tRNAiMet and eventually dissociates from the initiation 
complex (Algire et al., 2005). This leaves Met-tRNAiMet in the P site of the small ribosomal subunit 
and allows the final steps of initiation to occur. In this process, specific handling of the initiator tRNA 
by e/aIF2 and control of the nucleotide state of the factor are crucial for accuracy.  
According to its central role in translation, eIF2 was early identified as a central target in 
response to stress conditions (Gebauer and Hentze, 2004; Holcik and Sonenberg, 2005). Such 
conditions trigger phosphorylation of the α subunit of the heterotrimer that, in turn, leads eIF2 to form 
an inactive complex with the guanine nucleotide exchange factor eIF2B. The subsequent sequestering 
of eIF2 reprograms gene expression by both reducing global translation and specifically enhancing the 
translation of mRNAs encoding activators of the transcription of stress adaptation genes (Hinnebusch, 
2005). 
Proteomic studies in S. cerevisiae have reported interaction of the γ subunit of eIF2 with the 
cell proliferation protein Cdc123 (e.g (Ho et al., 2002)). This gene was first identified in mammals as 
the target of mutations blocking the G1-S transition in the cell cycle (Ohno et al., 1984; Okuda and 
Kimura, 1996). In human, CDC123 was described as a candidate oncogene in breast cancer (Adelaide 
et al., 2007) and implicated in other diseases (Soler Artigas et al., 2011; Zeggini et al., 2008). 
Relationships between eIF2 and Cdc123 became clearer when it was shown that assembly of the eIF2 
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complex in vivo depended on Cdc123 (Perzlmaier et al., 2013). Indeed, mutations of Cdc123 in 
budding yeast reduced the association of the eIF2 subunits, diminished polysome levels, and increased 
GCN4 expression indicating that Cdc123 was critical for eIF2 activity. Using co-immunoprecipitation 
from S. cerevisiae cell extracts as well as pull-down experiments with E. coli expressed proteins, an 
interaction between Cdc123 and the unassembled γ subunit of eIF2 was shown (Perzlmaier et al., 
2013). More precisely, the results have indicated that domain III of the γ subunit of eIF2 was required 
for binding to Cdc123. Alterations of the binding site revealed a strict correlation between Cdc123 
binding, the biological function of eIF2γ and its ability to assemble with α and β subunits. 
Overexpression of Cdc123 neutralized the eIF2 assembly defect. Moreover, overexpression of eIF2 α 
or γ subunits rescued an otherwise inviable cdc123 deletion mutant with a strong synergistic effect 
when both α and γ subunits were overproduced. In contrast, overexpression of eIF2β could not 
compensate for the absence of Cdc123. Thus, Cdc123 has appeared as an essential protein acting as a 
specific assembly factor of the eIF2 heterotrimeric complex by promoting the eIF2αγ assembly step 
(Perzlmaier et al., 2013). The requirement of Cdc123 in eukaryotes may explain why all attempts to 
produce isolated yeast eIF2γ were unsuccessful (Naveau et al., 2013). 
Here, we report the first crystal structure of a Cdc123 representative, that from 
Schizosaccharomyces pombe, both isolated and bound to the domain III of eIF2γ (γDIII) from 
Saccharomyces cerevisiae. Cdc123 resembles enzymes of the ATP-grasp family and indeed binds 
ATP-Mg2+. Structural data and biochemical studies revealed that ATP-Mg2+ is needed for Cdc123 
activity. A docking of eIF2αγ onto Cdc123 allows us to propose a tentative model explaining how 
Cdc123 participates in the biogenesis of eIF2  through facilitating assembly of eIF2γ to eIF2α. 
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RESULTS 
Overall structure of Sp-Cdc123 
Despite many attempts, no crystal could be obtained using Cdc123 from S. cerevisiae (Sc-
Cdc123). Therefore, we have chosen to purify Cdc123 from Schizosaccharomyces pombe, Sp-Cdc123. 
Indeed, the two proteins share 35% identities (55% similarities). Moreover, Sp-Cdc123 is shorter than 
Sc-Cdc123 (319 amino acids as compared to 360 in the case of Sc-Cdc123) with smaller predicted 
loop regions ((Cole et al., 2008); Figure S1A). Various crystal forms of full-length Sp-Cdc123 were 
obtained (Table S1). The 3D structure was solved using anomalous scattering data from crystals of 
selenomethionylated Cdc123, combined with non-crystallographic symmetry and multi-crystal 
averaging. The initial density map allowed us to trace most of the Cα backbone and to identify non-
crystallographic symmetry operators. This permitted partial refinement of a first 3D model of Sp-
Cdc123 at 3.24 Å resolution. This model contained residues 2-271 with the exception of residues 51 to 
71. The C-terminal part of the protein (272 to 319) was not visible in the electron density. We
suspected that mobility of this region within the crystals might have hampered the diffraction quality. 
Therefore, a C-terminal truncated form of Sp-Cdc123 (1 to 274, hereafter named Sp-Cdc123∆c) was 
engineered. High-resolution diffracting crystals could be obtained using Sp-Cdc123∆c (Table 1). The 
structure was solved by molecular replacement using the 3.24 Å resolution model and refined to 2.06 
Å resolution. Final statistics are given in Table 1. The final model contains two monomers of Sp-
Cdc123∆c in the asymmetric unit. As in the case of the model obtained with the full-length protein, 
residues 51 to 71 were not defined in the electron density for both monomers and loop 148-152 was 
difficult to model. Notably, the C-terminally truncated protein and the full-length protein were 
arranged as a tetramer within the crystals. Nevertheless, Sp-Cdc123 behaved as a monomer in 
solution, as shown by molecular sieving and SEC-MALS (see Experimental Procedures). 
The structure of Sp-Cdc123∆c monomer can be divided into two α−β domains. The N-
terminal domain contains residues 2 to 170 (domain 1) and the central domain contains residues 171 to 
274 (domain 2, Figure 1). A comparison of the Sp-Cdc123 structure to other known structures was 
performed using the Dali server (Holm and Sander, 1995). All high scoring entries in the PDB 
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belonged to the ATP-grasp family. Representative top scoring matches are shown figure S2B. All 
homologous structures shown in Figure S2B can be aligned to Cdc123 with Z-scores ranging from 8.3 
to 11.2 and rmsd in the 3 Å range for 156-179 aligned residues. ATP-grasp enzymes catalyze similar 
reactions, involving an ATP-dependent ligation of a carboxyl group carbon with an amino or imino 
group nitrogen. Catalysis proceeds, in each case, through the formation of an acylphosphate 
intermediate (Artymiuk et al., 1996; Fan et al., 1995; Galperin and Koonin, 1997). This homology was 
unanticipated according to the low sequence similarities of Cdc123 with proteins of the ATP-grasp 
family (in the 10% range, Figure S2) and had previously not been detected using standard BLAST 
procedures. The classical ATP-grasp fold is formed of three domains usually named, N, central and C 
domains (or A, B and C (Fawaz et al., 2011). The N domains are not structurally conserved between 
the various ATP-grasp enzymes. Comparison of ATP-grasp enzymes with Cdc123 (Figures 2 and S2) 
shows, however, that the structural homology is restricted to the central and C domains (equivalent to 
domains 1 and 2 in Cdc123, respectively; Figure 2C). Indeed, the N terminal domain of ATP-grasp 
enzymes (colored gray in  Figure S2B) is not observed in Cdc123 proteins. Domain 1 of Cdc123 
contains a three-stranded β-sheet, whereas the corresponding β-sheet in ATP-grasp enzymes contains 
a fourth strand (Figure 2B). Residues forming this additional strand are inserted between β2 and β3 
counterparts of Cdc123 domain 1 (Figure S2A). Domain 2 of Cdc123 contains a four-stranded 
antiparallel β-sheet with a topology similar to that observed in the C-terminal domain of ATP-grasp 
enzymes (Figure S2). A fifth β-strand is observed at the C-terminal part of Cdc123∆c. Finally, within 
domains 1 and 2, regions specific to Cdc123 are inserted or divergent (colored green in Figure 2 and in 
Figure S2). Among these are regions involved in ATP binding in grasp enzymes (colored orange in 
Figures 2 and S2 (Fan et al., 1995)). 
Despite these differences, the obvious resemblance of Cdc123 with ATP-grasp enzymes 
suggested that Cdc123 had the ability to bind ATP. 
Cdc123 binds ATP 
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As an attempt to evidence ATP binding by Sp-Cdc123, a titration of the protein with ATP was 
followed using ITC (Experimental Procedures). A dissociation constant of 67 ± 13 µM could be 
deduced from the titration curve (Figure S3). This Kd value is in the same range as that measured for a 
typical ATP-grasp enzyme, the S. aureus D-alanine:D-alanine ligase (60µM, Liu et al ., 2006). This 
result shows that Sp-Cdc123 indeed binds ATP with significant affinity. 
In order to obtain further insight into ATP binding, crystallization trials with Sp-Cdc123∆c 
were performed in the presence of ATP-Mg2+, AMP-PNP-Mg2+ and ADP-Mg2+. Crystals isomorphic 
to crystals with unliganded Sp-Cdc123∆c were obtained and datasets were collected. However, a 
bound nucleotide was only observed when crystals were prepared in the presence of AMP-PNP. In 
this case, there was no density for the γ-phosphate group in the maps and therefore the density was 
assigned to an ADP molecule. Instability of AMP-PNP in acidic conditions has been reported (Sigma-
Aldrich product information sheet) and could explain the presence of ADP instead of AMP-PNP. Only 
one ADP molecule bound to monomer A was clearly identified (Table 1, Figure 3). No magnesium 
ion bound to ADP was observed. In monomer B, residual electron density within the pocket was 
attributed to water molecules. Their positions may reflect low occupancy of ADP. Possibly, packing 
constraints may have hampered tight binding of ADP to the second monomer. 
In monomer A, ADP is bound in a position corresponding to the ATP binding pocket 
previously identified in ATP-grasp enzymes, at the interface between the domain 1 and domain 2 
(Figures 1 and 2). One side of the ADP molecule is held by residues located in domain 2 of Cdc123, 
belonging to motifs conserved in all ATP-grasp enzymes (yellow residues in β4-β7, Figure 3A). At 
the opposite side, some residues belonging to domain 1 participate in the binding of ADP (residues 
164-167, blue residues in Figure 3A). Additional contacts involve residues located in non-conserved 
regions (residues 99, 101, 103, colored green in Figure 3A). Interestingly, the two regions 
corresponding to the loops involved in ATP binding in ATP-grasp enzymes, named “small loop” and 
“large loop” (Figure 2B and S2, residues 176-180 and 233-261 in 1E4E), are highly divergent in 
Cdc123. These two regions of ATP-grasp enzymes form a lid in the presence of ATP, interacting 
together above the ATP binding cavity (Figure 2B and S2 (Fan et al., 1995; Hara et al., 1996; Roper et 
al., 2000; Zhao et al., 2013)). In place of the small loop segment, region 98-110 contains stretches of 
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residues highly conserved in Cdc123 proteins (Figure S1). Finally, comparison of the structure of 
unliganded Cdc123 with that of ADP-bound Cdc123 only showed adjustments of side chains involved 
in the binding of ADP. 
Overall, analysis of the ADP binding site in Cdc123 shows that nucleotide binding involves 
regions and residues of the protein that are conserved in ATP-grasp enzymes (Figure S2). This 
observation makes a strong case for a common ancestry of Cdc123 and ATP-grasp enzymes. 
However, significant differences are observed within their respective ATP binding sites. Such 
divergences are likely to be linked to the biological function of Cdc123. Overall, Cdc123 may be 
considered as an atypical member of the ATP-grasp family. 
Notably, a second cavity faces the nucleotide-binding pocket in Cdc123 (Figure 3B). This 
cavity is walled by residues V10, C13 and Q14 from α1 on one side and by residues H134, D135 and 
F140 from α6 on the other side. In addition, the side chains of R246 and W99 are positioned at the top 
and bottom of the cavity, respectively. In the ADP-bound structure, the cavity is filled up by electron 
density attributed to five water molecules. According to the location of the second binding pocket and 
to the homology with the ATP-grasp enzymes, it is conceivable that this pocket corresponds to a 
binding site for a second ligand of Cdc123, substrate of a reaction involving an ATP-dependent 
ligation step as observed in ATP-grasp enzymes. The existence of such an unidentified second ligand 
remains however hypothetic at this stage. 
Binding of Cdc123 to eIF2γ 
In vivo assembly of the eIF2 complex was shown to depend on Cdc123. Sc-Cdc123 activity 
involved an interaction with the unassembled eIF2γ subunit (Perzlmaier et al., 2013). eIF2γ is made of 
three domains: the GTP-binding domain, γDI, and the two β-barrels γDII and γDIII (Schmitt et al., 
2010). Within eIF2γ, domain III was shown to be sufficient for binding to Cdc123 (Perzlmaier et al., 
2013). 
According to these results, we evidenced in vitro interaction of Sc-Cdc123 to Sc-eIF2γDIII 
domain (domain III of eIF2γ from S. cerevisiae) using molecular sieving experiments (Figure S3 and 
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Experimental Procedures).  Interestingly, the behavior of Sc-Cdc123 on the molecular sieve column 
suggested that the protein was dimeric in its unliganded form and became monomeric upon binding to 
eIF2γDIII (Figure S3). The Kd value for the binding of Sc-eIF2γDIII to Sc-Cdc123 was 2.5 ± 0.5 µM, 
as measured using ITC (Figure S3). This value was measured in the absence of ATP. Hence, binding 
of Sc-eIF2γDIII to Sc-Cdc123 did not strictly require the presence of ATP-Mg2+. Despite several 
attempts, no crystal could be obtained using the purified complex. Therefore, we decided to design a 
chimeric complex made of Sp-Cdc123 bound to Sc-eIF2γDIII. Formation of a stable complex was 
indeed observed by a pull-down experiment showing that an N-terminally his-tagged version of Sp-
Cdc123 can trap Sc-eIF2γDIII on a cobalt affinity resin. Upon elution with imidazole, a peak 
corresponding to a heterodimer of Sp-Cdc123 bound to Sc-eIF2γDIII was observed (Experimental 
Procedures). An additional step using molecular sieving allowed us to polish the purification (Figure 
S3). Notably, the binding of Sc-eIF2γDIII to Sp-Cdc123 did not produce sufficient heat changes to 
allow accurate determination of a Kd value using ITC. One possible explanation is that, in the case of 
the complex formed with the S. cerevisiae proteins, binding of Sc-Cdc123 to Sc-eIF2γDIII is 
accompanied by a change of the oligomeric state of Sc-Cdc123 from homodimer to monomer. Sp-
Cdc123 behaves as a monomer and binding to Sc-γDIII does not change its oligomeric state, possibly 
explaining why observed heat changes are weaker. 
Suitable crystals were obtained using the purified complex Sp-Cdc123:Sc-eIF2γDIII at 24°C 
in the presence or in the absence of ATP-Mg2+. The structure was solved by molecular replacement 
using the structure of Sp-Cdc123∆c determined in this study and the structure of aIF2γDIII from S. 
solfataricus (2AHO, (Yatime et al., 2006)) as search models. The structures were refined to 2.9 Å and 
3.0 Å resolution in the presence or in the absence of ATP-Mg2+, respectively (Table 1). 
Within the complex, the structure of the γDIII domain was defined from residue 423 to residue 
524 with only the 3 C-terminal residues not visible in the electron density. In Sp-Cdc123, all residues 
corresponding to the two core domains (from 2 to 274) were visible with the exception of two loops 
(residues 53 to 68 and residues 149 to 152). Residues 275 to 296 were not visible. However, additional 
electron density disconnected from the main structure was attributed to a long helix of the C-terminal 
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domain of Sp-Cdc123 (α10, residues 297 to 315). Superimposition of the structure of the complex 
obtained in the presence of ATP on that obtained without ATP showed only adjustments of side chains 
involved in the binding of ATP. 
Overall structure of Sp-Cdc123:Sc-eIF2γDIII 
Sc-eIF2γDIII forms a β-barrel highly homologous to the corresponding domain in archaeal 
aIF2 (Figure S4). Two differences are notable. In the eukaryotic domain, (i) the loop between β16 and 
β17 is longer and, (ii) β21 is extended by four residues in such a way that its interaction with strand 
β16 is reinforced. 
In the structure of the complex, the γDIII domain is bound to one side of Cdc123 domain 1. 
Neither Cdc123-domain 2 nor the C-terminal helix α10 does contact γDIII (Figure 4A). γDIII and 
Cdc123 closely interact together with an interaction surface of 1307 Å2. Interestingly, the binding site 
of γDIII to Cdc123 overlaps the dimerization site of Cdc123 observed in all crystal forms. In order to 
address the possibility that the observed position of γDIII to Cdc123 may have resulted from 
crystallization artifacts, a solution study was carried out using small angle X-ray scattering. The goal 
was to compare theoretical X-ray scattering curve deduced from the crystallographic structure with the 
scattering curve experimentally observed in solution. As shown in Figure 4B, the SAXS experimental 
curve obtained with the purified Sp-Cdc123:Sc-eIF2γDIII fits very nicely the curve calculated from 
the crystal structure coordinates. This strongly argues in favor of the biological significance of our 
crystalline model. 
Detailed interactions of Sp-Cdc123 with Sc-eIF2γDIII are shown in Figure 4C and D. Sc-
eIF2γDIII is mainly bound through its concave side formed by strands β17-β18-β19-β20-β21 of the 
barrel and by the β20-β21 loop (Figure 4D). On the side of Cdc123, the main regions of contacts 
correspond to α3 and the following loop (residues 44, 46-50), helix η2 (residues 107-110), α5 and α6 
(Figure 4C). Notably, the Cdc123 regions involved in the binding of Sc-eIF2γDIII correspond to 
regions specific of Cdc123 proteins, not found in ATP-grasp enzymes (Figures 2 and S2, green 
regions). Figures S1, S4 and Table 2 show residues involved in the heterodimer interface between 
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Cdc123 and γDIII. Superimposition of bound Cdc123 on unbound Cdc123 showed that binding to 
γDIII involved adjustment of the interface regions. In particular, α3 and the following loop are 
displaced and the conformation of the region around helix η2 (residues 107-110) is adjusted. This part 
of Cdc123 is connected to the ATP binding pocket (Figure 4C and D). Nevertheless, the Kd value of 
ATP measured by ITC for Sp-Cdc123:Sc-eIF2γDIII (57 ± 7 µM ) was not significantly changed as 
compared to that measured for isolated Sp-Cdc123 (67 ± 13 µM).   
Previous results had suggested that within domain III, the C-terminal tail, specific of 
eukaryotic eIF2γ was required for the interaction with Cdc123. Indeed, removal of thirteen amino 
acids at the C-terminal extremity of eIF2γ (residues 515 to 527) was sufficient to render the protein 
non-functional in the binding to Cdc123 or to eIF2α and eIF2β subunits (Perzlmaier et al., 2013). On 
the contrary, the removal of 4 amino acids from the C-terminus was tolerated, since binding to Cdc123 
and assembly with α and γ subunit still occurred (Perzlmaier et al., 2013). No direct interaction is 
observed between the C-terminal part of γDIII and Cdc123 in the structure of the complex. However, 
the structure shows that the last β-strand of γDIII (β21) is extended to residue 522. Therefore, it is 
likely that a deletion of residues belonging to β21 led to destabilization of the structure of the β-barrel 
and thereby impaired binding to Cdc123. According to these observations, the absence of C-terminal 
extension in archaeal aIF2γDIII cannot be straightforwardly related to the absence of Cdc123 from 
archaea. 
To further characterize the complex between Cdc123 and eIF2γDIII, mutations within γDIII 
were introduced. Three single mutants were produced, E460A, R504A and W509A. The effect of the 
mutations on association with Sp-Cdc123 was evaluated using pull-down assays (Figure S4). As 
predicted from the 3D structure, modification of R504 and W509 into alanine resulted in lower 
amount of Sp-Cdc123:Sc-eIF2γDIII complex retained on affinity column, as compared to that 
obtained with wild-type Sc-eIF2γDIII (Figure S4). In the case of E460A mutant, a lower level of 
protein expression did not allow us to reach a firm conclusion. 
ATP binding residues of Cdc123 are crucial for eIF2 assembly 
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Crystals of Sp-Cdc123:Sc-eIF2γDIII complex could be obtained in the presence of ATP-Mg2+
(Table 1). As shown in Figures 5 and S5A, ATP-Mg2+ is observed, firmly bound to Cdc123 in the 
presence of one Mg2+ ion. The octahedral coordination of the tightly bound magnesium ion is visible. 
In the equatorial plane, four bonds involve D239 and N241 side chains and two oxygens from the 
β and γ phosphate groups. Two water molecules are in apical positions. One of them is stabilized by 
D227, whereas the second water appears less stable. Superimposition of Sp-Cdc123:Sc-
eIF2γDIII:ATP on Cdc123∆c:ADP shows that the two structures are nearly identical in the area of the 
nucleotide, with only adjustments of side chain residues involved in the binding of Mg2+ and of the γ 
phosphate group (Figure S5B). 
Interestingly, in-line with the γ-phosphate of ATP is a water molecule located at 3.3 Å from 
the oxygens, at the entrance of the second cavity. This water molecule, stabilized by interactions with 
the main chain NH group of D248 and with the side chain NH2 group of R176, would be correctly 
positioned to participate in a possible ATP hydrolysis reaction (Figure 5A and  Figure S5B). At this 
moment, however, such an activity has not been firmly established. 
To get further insight into the role of ATP in eIF2 assembly, mutants of Sc-Cdc123 were 
designed and their behaviors were studied in vivo. 
We targeted residues involved in the coordination of the ATP-bound Mg2+ ion. Indeed, these 
residues (D227, D239, N241 in Sp-Cdc123) are highly conserved in Cdc123 sequences and in ATP-
grasp enzymes (Figures S1 and S2). Moreover, various studies of ATP-grasp enzymes have shown 
that these residues are essential for the enzymatic activity and suggested that Mg2+ had a catalytic role 
by maintaining ATP into a correct conformation for catalysis (Miller et al., 2005; Sloane et al., 2001). 
Therefore, we mutated the “DIN” sequence of Sc-Cdc123 (DIN; 266-268 in Sc-Cdc123 corresponding 
to 239-241 in Sp-Cdc123,  Figure S1) into three alanines. To test the effect of the DIN mutation in 
vivo, we used diploid yeast cells heterozygote for a CDC123 gene deletion, and expressing either wild 
type CDC123 or the DIN mutant (Figure 5B, right panel). No complementation of a deletion of the 
CDC123 gene was observed in the presence of the Sc-Cdc123 DIN. Moreover, the DIN mutant also 
failed to support assembly of Sc-eIF2γ with eIF2α (Figure 5B, left panel). This observation was made 
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in a S. cerevisiae strain deleted for CDC123 and kept alive by high-level expression of eIF2γ and 
eIF2α. Relative to a strain that carries the CDC123 gene, there was much less eIF2γ-eIF2α association 
in the cdc123 deletion mutant. Expression of the wild type version of Cdc123 restored normal eIF2γ-
eIF2α association. Expression of the Sc-Cdc123 DIN mutant, however, failed to increase the 
association of eIF2γ with eIF2α (Figure 5B, left panel). Thus, ATP-binding residues are essential for 
Cdc123 to support cell viability and eIF2γ-eIF2α assembly. Using co-IP experiments, we observed a 
defect of the DIN mutant in its interaction with full-length eIF2γ, whereas the amount of co-
precipitated eIF2α was unaffected by the DIN mutation (Figure S6A). This points to a link between 
ATP and the binding of full-length eIF2γ by Cdc123. 
To substantiate these observations, we analyzed another mutant of the ATP binding site of 
Cdc123, Sc-CDC123-D252A (equivalent to S. pombe D227) mutant. This residue, as D266 and N268, 
participates in the binding of the magnesium ion through a water-mediated interaction (Table 3). In 
line with the DIN mutant, Sc-CDC123-D252A failed to complement a CDC123 gene deletion and did 
not support assembly of eIF2γ with eIF2α (Figure 5B). Together, these data show that the DIN and 
D252A mutations disrupt both the biological and biochemical function of Cdc123. Hence, these 
results strongly argue in favor of a requirement on ATP binding for the vital cellular function of 
Cdc123 and for its role in promoting eIF2αγ assembly. 
Model for the catalytic complex 
In order to go forward in understanding the mechanism used by Cdc123 for eIF2 assembly, we 
performed a docking model for the binding of eIF2γ onto Cdc123. According to structural alignments 
and biochemical data, the 3D structure of the eukaryotic γ subunit is supposed to be very close to that 
of its archaeal counterpart (Schmitt et al., 2012). Therefore, to make the docking model, the Sc-
eIF2γDIII domain from the Sp-Cdc123:γDIII structure, was superimposed on the corresponding 
domain in aIF2γ structure (4RD4, (Dubiez et al., 2015)). In this model, shown in Figure 6A and B, the 
complete eIF2γ subunit is nicely anchored to Cdc123, without intertwining. Interestingly, the docking 
model revealed another potential contact between eIF2γ and Cdc123. This contact would involve the 
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long L1 loop of aIF2γ-DII domain and the loop linking β5 to α7 (residues 192-196) of Sp-Cdc123. 
Strikingly, L1 loop of e/aIF2γ-DII domain is known to mediate interaction between e/aIF2γ and 
e/aIF2α subunits (Naveau et al., 2013; Roll-Mecak et al., 2004; Schmitt et al., 2002; Yatime et al., 
2006). 
Importantly, the position of eIF2γ on Cdc123 is compatible with simultaneous binding to 
eIF2α. Indeed, the docking model can be completed by positioning the aIF2α subunit, thanks to the 
knowledge of the aIF2αγ structure (PDB ID Code 2AHO, (Yatime et al., 2006)). As shown in Figure 
6C, the model suggests an interaction of Cdc123 with the interface between α and γ subunits. Hence, 
the docking model opens the possibility that Cdc123 acts through transient interaction with the L1 
loop of γDII and domain 3 of eIF2α subunit. This interaction would be necessary for the assembly of 
eIF2γ and eIF2α. 
To test the docking model, we generated a mutant version of eIF2γ lacking part of the L1 loop 
and analyzed its interaction with Sc-Cdc123 and the α and β subunits in an Y2H assay. The L1 loop 
mutation had little or no effect on the interaction of eIF2γ with eIF2β, but disrupted the interaction of 
eIF2γ with eIF2α and reduced the interaction of eIF2γ with Cdc123 (Figure S6B). The Y2H data, 
therefore, confirm the L1 loop region as an α-γ binding site in eukaryotic eIF2 orthologs and support 
the notion of a physical contact between the L1 loop of eIF2γ and Cdc123, as predicted by the docking 
model. 
To further analyze the docking model, we asked for an interaction of Sc-Cdc123 with eIF2α. 
To this end, we over-expressed a flag3-tagged version of Sc-Cdc123 in a yeast strain whose 
endogenous eIF2α-encoding gene was fused to a myc13-tag. Indeed, eIF2α-myc13 was detected in 
anti-flag immunoprecipitates of Cdc123. This signal was specific, because it was absent from 
precipitates of a control strain, which lacked Cdc123-flag3 but expressed eIF2α-myc13 (Figure S6A). 
This experiment demonstrates a contact between Cdc123 and eIF2α or eIF2αγ. Compared to the 
relative amount of eIF2γ co-precipitated with Cdc123-flag3 from cell extracts, much lower levels of 
eIF2α-myc13 were recovered. The Cdc123- eIF2α or -eIF2αγ contact might therefore be transient. 
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DISCUSSION 
The present study revealed the 3D structure of the cell proliferation protein Cdc123. This 
protein resembles enzymes belonging to the ATP-grasp superfamily. As suggested by this 
resemblance, ATP binding to Cdc123 could indeed be evidenced using biochemical tools and 3D 
structure determination. ATP is bound by residues common to Cdc123 and ATP-grasp enzymes but 
also by residues specific to Cdc123. Moreover, ATP-grasp enzymes possess an N-terminal domain, 
which makes part of their catalytic center. This domain is absent in Cdc123. Overall, Cdc123 protein 
appears as a member of the ATP-grasp family having unique features. 
As in ATP-grasp enzymes, crucial residues are involved in the binding of the magnesium ion 
held on ATP. These residues (D252, D266, N268 in Sc-Cdc123 equivalent to D227, D239, N241 in 
Sp-Cdc123) were shown in this study to be essential for the cellular function of Cdc123. In the same 
view, it should be reminded that a temperature-sensitive mutant of a rat fibroblast line, arrested in the 
G1 phase of the cell cycle at restrictive temperature, was mapped within Cdc123 (Ohno et al., 1984; 
Okuda and Kimura, 1996). The mutation identified corresponds to a change of A109 into valine 
(equivalent to T101 in Sp-Cdc123). T101 indeed participates in the binding of ATP (Table 3). 
Therefore, this temperature-sensitive mutant gives further credit to the idea that ATP is needed for the 
cellular function of Cdc123. 
Previous studies had shown that Cdc123 was necessary for eIF2 assembly (Perzlmaier et al., 
2013). In particular, interaction between unassembled eIF2γ and Cdc123 was evidenced, with DIII 
domain of eIF2γ being sufficient to trap Cdc123. Here, we determined the structure of Sp-Cdc123 
bound to the γDIII domain of eIF2. The γDIII domain of eIF2 is bound to Cdc123 via interactions 
involving only Cdc123-domain 1. Domain 2 and the C-terminal domain do not contact γDIII. This 
observation is consistent with results obtained using a yeast-2-hybrid assay and immunoprecipitation 
experiments, showing that C-terminal sequences of Sc-Cdc123 are dispensable for γ binding (Figure 
S6C). On the contrary, this C-terminal region is essential for Cdc123 function because cells carrying 
Cdc123∆291 are inviable (Figure S6C). Consistently, association of the eIF2 subunits was 
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compromised when a truncated version of Sc-Cdc123 (Sc-Cdc123∆327) was used (Perzlmaier et al., 
2013). 
Accordingly, the docking model suggests that the C-terminal domain of Cdc123 is involved in 
the assembly process of eIF2γ to eIF2α. Therefore, eIF2γ would be bound to Cdc123 by an anchoring 
point located in domain 1 of the Cdc123, as observed in the present Cdc123-γDIII structure. In this 
view, the Cdc123-γDIII structure might represent a “pre-assembly complex” (Figure 6). A second 
contact point, possibly dependent on ATP binding and/or ATP hydrolysis, involving domain 2 and the 
C-terminal domain of Cdc123 would be necessary for the reshaping of the interaction surface between 
eIF2γ and eIF2α. Once assembled, the eIF2αγ complex becomes stably folded allowing further 
spontaneous binding of the eIF2β subunit without the help of Cdc123 ((Perzlmaier et al., 2013) and 
our unpublished observations). After assembly, Cdc123 no longer interacts with eIF2 (Perzlmaier et 
al., 2013) even though the region of γDIII involved in Cdc123 interface remains accessible (Figure 
6C). This suggests that the release of Cdc123 might result from unfavourable interactions between the 
second contact point (domain 2 and C-terminal domain of Cdc123) and the reshaped 
eIF2αγ association surface. 
Notably, archaea do not display Cdc123 orthologs. Accordingly, assembly of aIF2 subunits 
occurs spontaneously in vitro (Pedulla et al., 2005; Stolboushkina et al., 2008; Yatime et al., 2006; 
Yatime et al., 2004). However, Sequence alignments highlighting the specificities of eukaryotic and 
archaeal e/aIF2γ do not give any obvious clue to explain the different behaviors of eIF2 and aIF2 
regarding the assembly of the heterotrimer (Yatime et al., 2007). 
Affecting ATP binding to Cdc123 led to the loss of Cdc123 function. Thus, our structural and 
biochemical data link the function of Cdc123 in eIF2 assembly to the cell energetics. This reinforces 
the idea that Cdc123 is an important control point of the eukaryotic cell cycle. The question of 
whether Cdc123 uses ATP in a chaperone-like fashion to support eIF2αγ assembly without covalent 
modification or whether Cdc123 uses ATP to introduce a post-translational modification in an effector 
site remains open. The existence of a second binding pocket identified in the structure rather argues in 
favor of the second possibility. However, for the while, our attempts to evidence modification in 
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purified eIF2γ subunit from cells expressing or not Cdc123 have been fruitless. Therefore, further 
studies are clearly required to reveal how Cdc123 uses ATP to favor the assembly of eIF2. 
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EXPERIMENTAL PROCEDURES 
Protein expression and purification 
Sp-Cdc123 
The gene coding for Sp-Cdc123 was amplified from a cDNA library (generous gift from 
François Lacroute, INRA, Grignon, France) and cloned into pET3a and pET15b derivatives. The 
resulting plasmids called pET3a-SpCdc123 and pET15b-SpCdc123 led to the expression of an 
untagged and an N-terminally tagged version of Sp-Cdc123, respectively. To express the protein, the 
desired plasmid was transformed into E. coli BL21 Rosetta pLacI-Rare (Merck, Novagen). 1 L 
cultures were in 2xTY containing 50 µg/mL of ampicillin and 34 µg/mL of chloramphenicol. 
Expression was induced by adding 1 mM of IPTG in an overnight 37°C culture. After induction, the 
cultures were continued for 5 hours at 18°C. 
For untagged Sp-Cdc123, cells corresponding to 1 L of culture were disrupted by sonication in 
30 mL of buffer A (10 mM HEPES pH 7.5, 200 mM NaCl, 3 mM 2-mercaptoethanol, 0.1 mM PMSF, 
0.1 mM benzamidine). The crude extract was loaded onto a Q-Sepharose column (16 mm x 20 cm; 
GE-Healthcare) equilibrated in buffer A. A gradient from 200 mM NaCl to 1 M NaCl was used for 
elution (200 mL at a flow rate of 2.5 mL/min). This step was repeated twice. The recovered protein 
was loaded onto a Superdex 200 10/300 (GE-Healthcare) equilibrated in buffer A. The Sp-Cdc123 
pool was concentrated to 10 mg/mL. Sp-Cdc123 behaves as a monomer in solution, as shown by 
conventional size-exclusion chromatography coupled to multi-angle static light scattering (SEC-
MALS, Wyatt). 
A truncated version of Sp-Cdc123 was engineered by introducing a stop codon in place of 
codon 275. The obtained plasmid, pET15b-SpCdc123∆c produced a protein ending at residue 274 and 
carrying a poly histidine tag at the N-terminal extremity. pET15b-SpCdc123∆c was transformed into 
E. coli BL21 Rosetta and expression was obtained as described above. After sonication, the crude 
extract was loaded onto a column (4 mL) containing Talon affinity resin (Clontech) equilibrated in 
buffer B (10 mM HEPES pH 7.5, 500 mM NaCl, 3 mM 2-mercaptoethanol, 0.1 mM PMSF, 0.1 mM 
benzamidine). The protein was eluted with buffer B containing 125 mM imidazole. The recovered 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
19 
protein was then loaded onto a Superdex 200 column (10/300; GE Healthcare) equilibrated in buffer 
B. The Sp-Cdc123∆c pool was concentrated to 10 mg/mL. 
Sp-Cdc123:Sc-γDIII complex 
The gene coding for the γDIII domain (fragment 410-527) of Sc-eIF2 from PWS3915 
(Perzlmaier et al., 2013) was cloned in pET3alpa. The obtained plasmid pET3a-Sc-γDIII was 
transformed into E. coli BL21 Rosetta and expression was obtained as described above. 
To purify the Sp-Cdc123:Sc-γDIII complex, pellets corresponding to 1 liter of culture of BL21 
Rosetta E. coli cells transformed with pET3a-Sc-γDIII and to 1 liter of culture of BL21 rosetta E. coli 
cells transformed with pET15b-Sp-Cdc123 were resuspended in buffer B (10 mM HEPES pH 7.5, 500 
mM NaCl, 3 mM 2-mercaptoethanol, 0.1 mM PMSF, 0.1 mM benzamidine) and mixed.  After 
sonication, the crude extract was loaded onto a column (4 mL) containing Talon affinity resin 
(Clontech) equilibrated in buffer B. Finally, the protein complex was eluted with buffer B containing 
125 mM imidazole. The recovered protein complex was finally loaded onto a Superdex 200 column 
(10/300; GE Healthcare) equilibrated in buffer B. Fractions containing Sp-Cdc123:Sc-γDIII were 
pooled and concentrated to 10 mg/mL (Figure S3B). 
Crystallization and structure determinations 
Sp-Cdc123 
Initial crystallization trials were performed at 4°C and 24°C using sitting drops made with a 
Mosquito robot (TTP Labtech) and standard commercial kits (Hampton Research and Qiagen). 
Crystals were rapidly obtained using full-length Cdc123 in the presence of PEG3350 as precipitating 
agent at 24°C (see detailed conditions in Table S1). Diffraction data were collected at 100 K (λ=0.984 
Å) on the Proxima-1 beamline at the SOLEIL synchrotron (Saint-Aubin, FRANCE) equipped with a 
Pilatus detector. Data corresponding to crystals belonging to various space groups were collected 
(Table S1). These crystals diffracted to a maximum of 3.0 Å resolution. Diffraction images were 
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analyzed with XDS (Kabsch, 1988), and the data were processed with programs of the CCP4 package 
(Collaborative computational project No.4, 1994). 
 Crystals were also obtained using the selenomethionylated version of full-length Cdc123. 
Highly redundant anomalous datasets were collected at 100K at a wavelength corresponding to the 
maximal absorption of selenium (λ=0.9792 Å). According to the weak diffraction pattern and to the 
modest resolution limit of diffraction (around 4 Å), two datasets collected from Se-met crystals grown 
in the same drop, were merged. A first experimental map was calculated at 5.5 Å resolution using the 
automated SAD phasing procedure of the Solve program within the Phenix suite (Adams et al., 2010). 
A first round of automatic building was performed within this map using the “Phase and Build” 
function in Solve. The partial model allowed determination of the non-crystallographic symmetry 
operators. In a second step, a dataset corresponding to a crystal of full-length Cdc123 obtained in 
space group P212121 was used to perform multiple crystal averaging (Table S1). The quality of the 
resulting map was clearly improved and allowed manual building of a first model in Coot (Emsley et 
al., 2010). During manual building, the Dali Server was used to search for possible homologous 
structures. The crystal structure of the D-alanine--D-Alanine Ligase from Bacillus anthracis 
complexed with ATP (PDB ID code 3R5X) was identified and then used as a guide to facilitate further 
model building. In the course of refinement, the dataset corresponding to a crystal belonging to space 
group C222 was finally used to complete building of the model (Table S1). The preliminary structure 
of Cdc123 was partially refined to 3.24 Å resolution (R=0.2689, Rfree=0.3079). This first model 
revealed that full-length Cdc123 was only partly defined in the electron density with residues 274 to 
319 being not visible. Therefore, in order to improve the quality of the crystals, a C-terminally 
truncated form of Cdc123 was then engineered. Crystals obtained with the C-terminally truncated 
form of Cdc123 (Sp-Cdc123∆c) diffracted to 1.85 Å resolution (see detailed conditions in Table 1). 
New datasets were collected in the presence or in the absence of ATP or ATP analogs (Table 1). The 
3.24 Å resolution model was used to solve the structures by molecular replacement using Phaser. The 
final structures of Cdc123∆c were refined to 1.85 Å and 2.06 Å resolution, in the presence or in the 
absence of ADP, respectively, using standard procedures in Phenix. Final statistics are shown in Table 
1. 
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Sp-Cdc123:Sc-eIF2γDIII complex 
The complex stored in buffer B was used for crystallization trials. Crystals were obtained in 
the presence of 25% PEG3350 and 0.2 M LiSO4 with or without ATP-Mg2+ (see detailed conditions in 
Table 1). Datasets were collected on the PX1 beamline at the SOLEIL synchrotron (Saint-Aubin, 
FRANCE). The same procedure as the one described above was used to process the data. The structure 
was solved by molecular replacement with Phaser (Storoni et al., 2004), using the Cdc123∆c structure 
determined in this work and the γDIII domain from archaeal aIF2γ (PDB ID code 2AHO) as search 
models. The final structures were refined to 2.9 Å and 3.0 Å resolution in the presence or in the 
absence of ATP-Mg2+, respectively (Table 1). According to the relatively modest resolution of the 
dataset as well as to the high B value of the structure, attribution of the sequence in the disconnected 
helix 275-296 remained tentative. 
Accession numbers 
Structure coordinates, 4ZGO (Sp-Cdc123∆c), 4ZGP(Sp-Cdc123∆c:ADP), 4ZGN (Sp-
Cdc123:Sc-γDIII:ATP), 4ZGQ (Sp-Cdc123:Sc-γDIII) have been deposited to the PDB. 
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FIGURE LEGENDS 
Figure 1: Structure of Sp-Cdc123 
A-Schematic representation of the topology of Sp-Cdc123∆c. The β-strands are represented as arrows 
and the helices as rods. Secondary structure elements were assigned with PROCHECK (Laskowski et 
al., 1993). Domain 1 is colored in blue (residues 1-170) and domain 2 is colored in yellow (residues 
171-274). 
B-Cartoon representation of Sp-Cdc123∆c. Same color code as in view A. ADP is shown as sticks. 
Secondary structure elements are labeled. All structural views are drawn with PyMol (Schrodinger, 
2010). 
See also Figure S1. 
Figure 2: Comparison of sp-Cdc123 with D-alanyl-D-lactate ligase from ATP-grasp superfamily 
A-Left: cartoon representation of Sp-Cdc123∆c. Domain 1 is colored in blue and domain 2 is colored 
in yellow except for regions specific to Cdc123 proteins which are colored in green. ATP is shown in 
sticks. Right: cartoon representation of (VanA) from Enterococcus faecium (PDB ID Code 1E4E, 
(Roper et al., 2000)). For the sake of clarity, the N-terminal domain is not represented. Parts of the 
central domain of 1E4E similar to Cdc123 are colored in blue, parts of the C-domain of 1E4E similar 
to Cdc123 are colored in yellow. Divergent regions as compared to Cdc123 are shown in green. The 
small and large loops overhanging ATP are shown in orange. ATP and a phosphorylated inhibitor 
bound to VanA are shown in sticks and spheres. The Magnesium ion is shown as a green sphere. 
B-Left: Close-up view of the domain 1 of Sp-Cdc123 showing the three stranded β-sheet. Right: 
Close-up view of the central domain of 1E4E showing the four-stranded β-sheet and the two loops 
surrounding ATP. The color code is the same as in panel A. This view highlights the differences 
within the ATP-binding site between Cdc123 and the representative from the ATP-grasp family. 
See also Figure S2. 
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C-Superimposition of the ATP-grasp core domain of Cdc123 (in blue and yellow, as in view A) onto 
the corresponding one in 1E4E (in grey). For the sake of clarity, divergent regions have been omitted. 
Figure 3: Binding of ADP to Sp-Cdc123∆c 
A-The residues involved in ADP binding and the corresponding electrostatic bonds are shown. Color 
code is the same as in Figure 2A. Water molecules are in red spheres. 
B-Molecular surface representation of Sp-Cdc123∆c. Color code is the same as in Figure 2A. The 
view highlights the second cavity facing the ATP binding pocket. 
See also Figure S3. 
Figure 4:Structure of Sp-Cdc123:Sc-eIF2γDIII complex 
A-Overall structure of Sp-Cdc123:Sc- eIF2γDIII complex. Sp-Cdc123 is colored as in Figure 1B. ATP 
is shown with sticks and Mg2+ with a green sphere. Sc-γDIII is shown in orange. 
B-Solution studies using SAXS. The experimental SAXS curve (blue) is compared with the theoretical 
diffusion curve deduced from the crystalline structure of Sp-Cdc123:Sc-γDIII complex (red). 
C-Close-up view of Sp-Cdc123:Sc-γDIII showing the proximity of the ATP-binding pocket with the 
interface between the two proteins. 
D-Detailed interactions between Sp-Cdc123 and Sc-γDIII. The residues involved in the stabilization of 
the interface between the two proteins and the corresponding electrostatic interactions are shown (see 
also Table 2). The right view is rotated by 180° as compared to the left view. 
See also Figure S4. 
Figure 5: Binding of ATP-Mg2+ to Sp-Cdc123:Sc-γDIII complex 
A-The residues involved in ATP binding and the corresponding electrostatic interactions are shown. 
Color code is the same as in Figure 3A. Water molecules are in red spheres and the magnesium ion in 
green sphere. 
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B- Right panel: Failure of Cdc123-DIN (DIN266-268AAA) and Cdc123 D252A to support cell 
viability. Diploid yeast cells heterozygote for a CDC123 gene deletion and expressing either a wild 
type copy of CDC123 (upper panel; W14145), DIN (DIN266-268AAA; middle panel; W13936) or 
D252A (lower panel; W13935) mutant versions of CDC123 were sporulated and subjected to tetrad 
dissection. Left panel: Failure of Cdc123-DIN (DIN266-268AAA) and Cdc123 D252A to support 
interaction of eIF2γ with eIF2α. In yeast strains that overexpress a flag-tagged version of eIF2γ 
/Gcd11 and eIF2α /Sui2 and that carry either the endogenous wild type copy of CDC123 (W7743; 
lane 1) or are deleted for CDC123 (cdc123-Δ; lanes 2-5; W7745 lane 2) and express a wild type copy 
(W13930; lane 3), the DIN mutant version of CDC123 (W13931; lane 4) or D252A (W14238; lane 5). 
Cdc123, eIF2γ and eIF2α were detected by Western analysis of whole cell extracts (WCE). Flag-
tagged eIF2γ was immunoprecipitated (IP) and precipitates were analyzed for the presence of eIF2α 
(Co-IP). Flag-eIF2γ was precipitated and detected with the monoclonal flag antibody M2. Cdc123 and 
eIF2α were detected by rabbit antisera. 
See also Figure S5. 
Figure 6: Model for the binding of Cdc123 to eIF2αγ  
A-Molecular surface representation of Sc-Cdc123: Sc-eIF2γDIII complex. Color code is the same as 
that used in Figure 4. 
B-Docking of aIF2γ onto Sp-Cdc123. 
Sc-eIF2γDIII domain from the Sp-Cdc123:γDIII structure, was superimposed on the corresponding 
domain in aIF2γ structure (4RD4, Dubiez et al., 2015). Sp-Cdc123:γDIII is colored as in view A. 
Domain I of aIF2γ is colored in green, domain II of aIF2γ is colored in red. An arrow indicates the 
long L1 loop responsible for the binding of aIF2γ to aIF2α (Yatime et al., 2006). 
C-Docking of aIF2αγ onto Sp-Cdc123. 
Sc-eIF2γDIII domain from the Sp-Cdc123:γDIII structure, was superimposed on the corresponding 
domain in aIF2αγ structure (see text, 2AHO, (Yatime et al., 2006)). Color code is the same as in view 
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B for aIF2γ and Cdc123. aIF2α is colored as follows: Domain 1 in dark blue, domain 2 in light blue 
and domain 3 in cyan. 
On the right of the structural views are schematics illustrating domain contacts within models of 
Cdc123:eIF2γ and Cdc123:eIF2αγ complexes. 
See also Figure S6. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
domain 1 domain 2
α1
α2
β1β2
β3
α3
50
72
α4
η2
α5
α6
148
152
β4
β5
α7
α8
β6β7
α9
β8
A
B
2
274
α1  7-12 α2  15-25
β1	  29-32
α4	  76-88
β2	  94-97
α5	  119-127
α
6	  1
30
-1
37
β5	  183-189
α7	  196-199 α8	  202-214
β6	  224-232
β7	  234-242
β8	  268-270
ATP 
binding 
site
?
50
72
274319
β3	  161-165 β4	  174-180
α
3	  3
7-
43 α
9	  2
54
-2
59
Figure 1
α1
α2
β1
β2
β3
α3
50
72
α4
η2
α5
α6
148
152
α7
α8
α9
β4 β5β6β7
β8
α1
α2
β1
β2
β3α4
α8
β4 β5
β6
β7
small loop
large loop
β1
β3
β2
β1
β3
β2
β
small loop
large loop
A
B
η2
α4 α4
176
180
236
242
98
110
C
α1
α2
β1
β2β3
α4
α8
β4 β5
β6β7
Figure 2
Aβ2
β3
β1
α6
β4β6β7
α1
α2
η2
B
E174N241 R190D239
W99
F167
R176
D227
K164 E165
T101
K103
D135
H134
R246
F140
V10
C13
Figure 3
α1
α2
β1
β2
β3
5269
α4
η2
α5
α3
148 152
β4 β5
α7
α8
β6
β7
α9
β8
2
274
297
315
α6
524423
β16
β17
β18
β19
β20β21
W509
S128
D130R504
K507
E506
H44
N137
S489
T109
M463
W107
α6
η2
β21
β20
β16
β17
β18
β19
α5 β6β7
α1
α2
α3
α6
α5
N459
Y49
V50
E460
V461
R503
I48
D46
K127
D130
R504 β21
β20
β18
β19
β16
β17
52
69
E457
E506
α6α5
η2
β1
β3
β2
β21β20β17β18
β19β16
α3
S489
T109
W107
D130
E506
A470 M463
H44
A
B
D
C
χ=1.77
Figure 4
E174
N241
R190
D239
K96
W99
F167
R176
D227
K164
E165
T101
K103
A
B
3.3Wat1
Wat2
Wat3
Figure 5
L1 loop 
eIF2γDII 
274
eIF2γDI 
eIF2γDIII 
297
315
Cdc123 
D1 Cdc123 
D2
eIF2γ
DII 
eIF2γDI 
eIF2γ
DIII eIF2α
D3 
eIF2α
D2 
eIF2α
D1 
Cdc123 Domain2 Cdc123 C-terminal 
domainCdc123 Domain 1
297
315
274
eIF2γDIII 
Cdc123 
D1 Cdc123 
D2
eIF2γ
DII 
eIF2γDI 
eIF2γ
DIII 
Cdc123 
D1 Cdc123 
D2
eIF2γ
DIII 
Cdc123-eIF2γ complex
Catalytic complex-eIF2αγ 
assemblyeIF2γDIII 
eIF2γDI 
eIF2γDII 
eIF2α
D3 
eIF2α
D2 
eIF2α
D1 
297
315
A
B
C
Cdc123-eIF2γDIII complex:
« pre-assembly complex »
Figure 6
  
 
Data Collection 
Sp-Cdc123∆c 
 
Sp-Cdc123∆c 
+ADP 
Sp-Cdc123:Sc-DIII 
+ATP-Mg2+ 
Sp-Cdc123:Sc-DIII 
 
Crystallization  
Conditions 
 
4% tacsimate 
pH 5.0 
12%PEG3350 
4% tacsimate pH5.0 
12%PEG3350 
 
0.2M LiSO4 
0.1M Tris pH 8.0 
25%PEG3350 
0.2M LiSO4 
0.1M Tris pH 8.0 
25%PEG3350 
Space group C2 C2 C2221 C2221 
Cell dimensions     
    a, b, c (Å) 85.6 91.7 86.2 86.5 91.4 86.0 74.3 116.6 132.6 75.0 117.4  132.4   
 ()  90 93.5 90 90 91.4 90 90 90 90 90 90 90 
Resolution (Å) 45.8-2.06 43.2-1.85 45.0-2.9 45.7-3.0 
Rsym (%) 5.0 (90.8)a 3.3 (47.4) 7.4 (87.5) 10.2 (117.3) 
I/I 15.7 (1.3) 19.0 (2.7) 15.8 (2.2) 13.4 (2.0) 
CC1/2 (%) 99.9 (77.5) 99.9 (78.6) 99.9 (80.4) 99.9 (87.4) 
Completeness (%) 99.0 (94.3) 98.1 (96.4) 99.7 (99.3) 99.6 (97.8) 
Redundancy 5.5 (5.1) 3.0 (2.9) 5.8 (5.9) 7.3 (7.0) 
     
Refinement     
Resolution (Å) 45.8-2.06 43.2-1.85 45.0-2.9 45.7-3.0 
No. reflections 41180 56270 13237 12020 
Rwork / Rfree 0.193 (0.230) 0.183 (0.221) 0.195 (0.262) 0.218 (0.257) 
No. atoms/B-factors (Å2)     
Protein Mono1Cdc123 
2075/57.9 
Mono2Cdc123 
2060/66.4 
Mono1Cdc123 
2096/35.5 
Mono2Cdc123 
2048/44.0 
Cdc123  
2288/101.7 
D3  
805/100.0 
Cdc123  
2234/110.3 
D3  
798/100.3 
Water 198/62.5 331/44.3 5/72.8  
Ligand 
 
 
 
ADP-mono1/27/38.4 
 
ATP 31/82.1 
Mg 1/72.6 
 
 
R.m.s. deviations     
    Bond lengths (Å) 0.008 0.008 0.009 0.008 
    Bond angles () 1.09 1.10 1.18 1.05 
Table 1:  Data collection and refinement statistics for Sp-Cdc123 structure determination  
A single crystal was used for data collection. 
aValues in parentheses are for highest-resolution shell. 
 
Table 1
Sp-Cdc123 Sc-DIII distances (Å) 
Electrostatic bonds 
H44 N1 K507 N 3.1 
D46 O2 E506 N (mc) 3.0 
S47 O E460 O2 3.2 
I48 O (mc) V461 N (mc) 2.7 
V50 N (mc) N459 O (mc) 3.0 
S47 N (mc) R504 O (mc) 2.8 
K127 O R504 Nh1 3.3 
D130 O1 R504 Nh2 2.7 
S128 O (mc) W509 N 3.3 
Non-bonded contacts 
Y49 E457 
W107 M463-A470-T471- G472 
I108 T488-S489 
T109 T488-S489 
T110 T488-S489 
A133 K507 
L136 K507 
N137 K507 
L43 K507 
S47 R503 
D46 I505 
Table 2: Summary of interactions involved in the binding of DIII domain to Cdc123. Residue names 
are colored according to Figure S2. 
Table 2
Sp-Cdc 123 ATP binding 
Sp-Cdc123:Sc-γDIII 
distances 
(Å) 
Electrostatic bonds 
K96 Nζ O1α 
O2β 
2.9 
3.3 
T101 Oγ1 O3α 
O1β 
3.0 
2.8 
K164 Nζ O1α 
N7 adenine 
2.8 
2.9 
E165 O (mc) N6 adenine 3.0 
F167 N (mc) N1 adenine 3.2 
E174 Oε1 
         Oε2 
O2’ ribose 
O3’ ribose 
3.3 
2.9 
R176 O3γ 3.0 
R190 Nh1 
          Nh2 
O2α 
O3γ 
2.8 
2.9 
D227 Oδ2 Wat3 2.7 
D239 Oδ2 Mg2+
O2β 
2.1 
2.9 
N241 Oδ1 Mg2+ 2.2 
Wat2 Mg2+ 2.7 
Wat3 Mg2+ 2.5 
Non-bonded contacts 
K103 O1γ 
O1β 
S100 O1γ 
O1β 
I238 O1β 
O2β 
L114 O4’ ribose 
W166 N6 adenine 
N1 adenine 
C2 adenine 
V94 N6 adenine 
M169 C8 adenine 
N7 adenine 
C5 adenine 
Table 3: Summary of interactions involved in the binding of ATP to Sp-Cdc123:Sc-γDIII. 
Residue names are colored according to Figure S2. 
Table 3
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Figure S1: Sequence conservation among Cdc123 orthologs 
A-c.a 200 sequences of Cdc123 orthologs were aligned using ClustalW (Larkin et al., 2007). The 
consensus sequence was calculated using JalView (Waterhouse et al., 2009). The figure was drawn 
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S.pombe/1-319     
1 10 20 30  
S.pombe/1-319                                                                C    W           L K V H Q S  Y FR T K   I...............................................MTLI T NQ L F S SL KL P AKV K
S.cerevisiae/1-360                                                            C    W               V R V H S S  Y KS L......................................MSSQEYTTFIDIP T EQ E Y L SSL PKYVP IV K
H.sapiens/1-336                                                            C    W               M K V H Q S  Y FR T KS L................................................... K EH L F A PF GV I VI .
A.thaliana/1-333                                                         V  C    W               M R Q Q  Y FK T KT................................................... KEDE N I N PR SL I KFH.
G.theta/1-392                                                                C    W               I R V  Q Q  W FR T KT IMHARLRPGTILLICTALVEANQLSWTKDIERVLPAMTSTVDIKKADPLAPK F KD CA I E PS PC I AF .
        
S.pombe/1-319     
     40 50 60 70 80
S.pombe     I      YL  D                                                               E    P    V P  AP ATVLK HE SIY EQ MNTVEEVDSEEDEE.................................SAPAYYPER IQ
S.cerevisiae  43  L      YL  D                                                               E    P    L ED FP LS KKFIQ EQ GIK PQEENSRSVYTEEIIR.............NEDNDYSDW DEDTATEFVQEVEPLID HQ
H.sapiens     29   L      YL  D                                                               E    P    V G EE FP P QNVKD LD GTL VS RDDPPTHSQPDSD...................DEA IQWSDDE.NTATLTAPE FAT
A.thaliana  22  L      YL  D                                                               E    P    P DD FP LK ESFIN ID SGPFLL HSVTNEDAMPNRVH................NFEEE FQVPEEASDDEPLNRPS EI
G.theta       34     L      YL  D                                                               E       L G EE FG LD KEDFFE LQ GLV PE VEPVTASSGRVKSKDDYSDSDFSSSSESEQGSNPD QSDPNNPDDQEQATRPK ID
TT   TT    TT   
 
S.pombe/1-319     
90 100 110 120 130 140 150
S.pombe         I    G V PKLNWS P DA W        C       LL   S     D       C                I A LG         K   I T SLK A EV   KS DFV H L AF  D      L EK KE A V T L TT G TT E L L A NH DD K FDNADGSVPKD....
S.cerevisiae 110      L  L G V PKLNWS P DA W        C       LL   S     D       C                 L A          R   I N TMK V EL    YI H L AF  DK KD NE . A A A T LP N NE N Y LNA N M QR KG V GDD...........I
H.sapiens     89       I  L G V PKLNWS P DA W        C       LL   S     D       C                 V A G         R   I N SLK L DI   KS DFI R F  D     K QE NS S F A Y AM S KT S F F T FTQP IH T DSPDPC.........
A.thaliana    93      I    G I PKLNWS P DA W       CC       LL   S     D       C D               I  LG         K   I S NL  EI   RS D L H L AY    E RES ET T I S A SP Q S TCFN A F S T FN DS S KVSSRP.........
G.theta      160         I    G V PKLNWS P DA W        C       IL   S     D       C                I A LG         K   I NLK V DV   KS DFA H L AF  D  V SK ED E F A T NVGE IS A I L V CH DA A GPNESETTVSVENQR
TTS.pombe/1-319     
   160 170 180 190 200 210 220 230
S.pombe          L LK          EFRCFV         QR     Y             I                   D Y D Y F  V  W M       K LI   D N Y E L D L D FVF V I..FS E E FP. HAST SKR AFC D . F KENI CYEK S LLKKLDTFPD..PD
S.cerevisiae 178       L LR          EFRVFV         QR     Y             I                   D Y F  V  W M L      K IVGA   D N Y D L D L E V F FV  V IKGLK D Q CD. NPA NAH T L . Y DELS TFKD D IVHDV LPK PDKS L
H.sapiens    160       L LR          EFRCFV         QR     Y             I                   D Y Y  V  W L A      K LIGI   D T Y D I E  D I F FVF I ..IE E K C.E IPG ENK S Y Q H SKQK EIRRC Q FFKKH QYK LDED R
A.thaliana   164       L LR          EFRCFV         QR     Y             I                   D Y F  A  W L M      K LVGI   E T F L D L E I F Y F V V..ES Y K YPS KPE SNE C V T PV LNEK LLKG E FFDDK RFE ESEN T
G.theta  243       L LR          EFRCFV         QR     Y             M                   D Y  A  W M M      K LVGI   D S  D L V E I F FVF A IRPTKVV K F.D KTS DEF S C SH F LEWRSQIVS R FYLNT RGR PLKT
 TT TT   TT TT     S.pombe/1-319     
         240       250       260       270 280 290 300
S.pombe              D NP    T  L   W E                                                    RAWLI   F   LFS  L M E I G IHKD.. I YPR DG S ES NSENMKP IRL PKGSMPST SAKYYTNRVPFDM AASEGENLLEFAQ
S.cerevisiae 256           D NP    T  L   W E                                                    KIFIV   F   LFS  I I E L GPRPFN I ARK DS N AA APPKNDV DYE RLVTRHNT RFASKEHSENHVPQDLVEASLNPEAIR
H.sapiens  237           D NP    T  L   W E                                                    KVWLI   F   LFT  L A LDSR.G F GEV DS E ISENNLNGDFSEVD QEQDSPAFRCTNSEVTVQPSPY SYRLPKDFVDLST
A.thaliana   242           D NT    T  L   W E                                                    RV LI   W   MYT  L I E V G ATKE.R K F CGS LP E EK HGECDEL LRI ESRLSVLP LKTAVPYDYLDVS GSGWAQVLKIVEE
G.theta      319           D NP    T  L   W E                                                    KVFLI   Y   LFS  L L D P LRQRDW F GGF QP K DE HESMRAD ARPQGANSADQE EDAVTWLSKIFFA GMQNYDW......
S.pombe/1-319     
310
S.pombe    KWQDLTNKSNE..............
S.cerevisiae 336 ELTQKWKELLSQQAKEESSDSESET
H.sapiens    316  GEDAHKLIDFLKLKRNQQEDD....
A.thaliana   321 EFQKDDQSSDEVA............
G.theta    .........................
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  with Espript (Gouet et al., 1999) and edited manually.  For the sake of clarity, only five representative 
Cdc123 sequences are shown. Residues conserved in 78-100% of the sequences are in white letters in 
red boxes. Residues conserved in 50-77% of the sequences are in red letters and boxed. Residues 
involved in ATP binding to Sp-Cdc123 are indicated with stars boxed in red. Residues involved in the 
binding of Sc-γDIII domain to Sp-Cdc123 are indicated with stars boxed in green. Secondary 
structures of Sp-Cdc123 are shown at the top of the alignment.  
B-From the above alignment, conservations at each position were analyzed by using Jalview. The 
PAM 250 similarity matrix was used in this step. Residues on Cdc123 were colored according to the 
similarity score with a linear scale from blue to red (rainbow scale of PyMol). The γDIII domain was 
colored in grey.  
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CDC123
CDC123                        L        TP    I                               MTLILT..KNQVLHCQ.FSSWYS FRKL....  KAKV KPIPATVLKYLHEDSIYVEQPMNTVEEVDSE
3R5X 78 
 
G                K     IL     I TP    L                                IPYSGSNMLSSGICMD NISKK  RYE.G E  DWIE T..............................
1E4E116 G                K     VA     I TP    I                                IPFVGCDIQSSAICMD SLTYI  KN.AG A  AFWV N..............................
4IWX 84 G                K     LL     I  P    A                                SYPLN.ESVAIARARD LRSMQ  ARQ.G DL VTGI H..............................
3VPD 73 G                K     AL     L QP    A                                IPVVN.RPEVIEACGD WATSV  AK.AG P  KTAL T..............................
1EYZ 98 G                R     LA     L T     A                                LNVVP.CARATKLTMN EGIRR  AEELQ P STYRF D..............................
1KEE112 G                R     AM     L T     A                                VTMIGATADAIDKAED RRFDV  KK.IG E ARSGI H..............................
1Z2P 77  P                R     LL     I  P    V                                KVLFLESSAIHDMMSS EEINA  IK.NN PI NSFS K..............................
1Z2P  
CDC123
     70 80 90 100 110 120 130 
CDC123                      AI   G     V K                            L      EDEESAPAYYPEREAIQLIEK  KEL ..GAV P LNWSTPKDALWITTTGSLKCTTAEEVLL LKSSDF
3R5X117                  D     L   G   P VVKP                     G     V      .............KME LNFDE DKL ..F L    ...................NS GSSVG KIVYDK
1E4E155                  D    AA       P  VKP                     G            ...............K DRPV  TFTY... VF   ..................ARS SSFGVKKVNSAD
4IWX122                  D    LI   G   P VVK                      G     V      ..............SP DTSD  DMV .GA L   L...................VE TQGIG VLAETR
3VPD111                  E    LM   G   P VLKP                     G     L      ..............DR EALR  EAF Y.. V    ...................VI SWGRL AKVTDR
1EYZ137                       AV   G   P IVKP                     G     I      ..............SESLFRE  ADI Y.. C    ................VMSSS KGQTF RSAEQL
1KEE151                  E    VA   G   P IIRP                     G     I      ..............TM EALA  ADV F.. C    .................SFTM GSGGG AYNREE
1Z2P116                  E    LL       P IVKP                     G            ..............SK EVIQ  QSKQLIL F    .................ENAQ TFNAHQMKIVLE
1Z2P  
TT TT TTCDC123
140 150 160 170 180 190
CDC123                              LVL          E    V                      VAHDLNHAFDDCKDFDNADGSVPKDFSFE   KEWFPMHAST FRCF KSKRLIAFCQRDDN........
3R5X153                               VVI   I      EI   I                      DELISMLETVFEWDS.............E   EKY K...GE  TCS FDGKQLPIISIRHAAEFFDYNA
1E4E189                               ILI   V      EV   VL                     ELDYAIESARQYDS..............K   EQA S.G..C  GCA  GNSAALVVGEVDQIRLQYGIF
4IWX158                               LV           DI   VV                     QAAESVIDAFRGLNA............HI  QEYIKEAQG.C  RCL  GDEVVAAIERRAKEGDFRSNL
3VPD146                                 I   V      DI   VV                     AAAEALLEHKEVLGGFQHQ.........LFY QEY EKP.GR  RVF  GERAIAAIYRRSAHWITNTAR
1EYZ175                               VIV   V      EI    V                     AQAWKYAQQGGRAGAG............R   EGV KFD..F  TLLT SAVDGVHFCAPVGHRQEDGDY
1KEE188                               LLI   L      E    VV                     FEEICARGLDLSPT.............KE   DES IGW..K YEME  RDKNDNCIIVCSIENFDAMGI
1Z2P155                                L    I       V    I                     QEGIDD...................IHFPC CQHY NHNN.KI KVFC GNTLKWQTRTSLPNVHRCGIK
TT TT1Z2P  
CDC123
200 210 220
CDC123                                                    I  L   L           ..........YYEFLKEN..........................IDCYEKL SD LKK DTFPD...PDF
3R5X207                                                     V  A       L       KYDDASTIEEV..............................IELPAELKER NK SLACYKA K.CSVYA
1E4E242                                                     I      I   L       RIHQEVEPEKGSENAVITVP.....................ADLSAEERGR QETVKK YKT G.CRGLA
4IWX215                                                        I   A   M       HRGGAAS.....................................VASITPQERE AIK ART A..LDVA
3VPD206                                                     I  L   A   V       GGQAEN.......................................CPLTEE AR SVG AEA G..GGVV
1EYZ231                                                     A  I   V   L       RESWQP...................................QQMSPLALER QE ARK VLA G.GYGLF
1KEE243                                                     M  A   V   I       HTGDSITVAPAQT..............................LTDKEYQI RN SMA LRE GVETGGS
1Z2P205                                                     M  L   V   L       SVDFNNQHLEDILSWPEGVIDKQDIIENSANRFGSKILEDPILLNLTSEAE RD AYK RCA GV..QLC
     TT         TT1Z2P  
       TT             TT   TT          TTCDC123
   230 240 250 260 270 280 290 
CDC123   DV          L DIN                                                   VF  YIHKD..RAW I   PFYPRTDGLLFSWSELESMNSENMKPEIRLIPKGSMPSTGSAKYYTNRVPF
3R5X246   VDM          V EVN                   I                               R   MVKDG..IPY M   TLPGMTQASLLPKSADAAG HYSKLLDMIIETSLRVRKEEGF.........
1E4E290   VDM         VL EVN                   I                               R   FLQDN.GRI  N   TLPGFTSYSRYPRMMAAAG SLPELIDRLIVLALKG...............
4IWX246   VDI         LV EVN                   M                               G   LRANR..GP  M   ASPGLEGIEKTTGIDIAGK IRWIERHATTEYCLKTGG.............
3VPD235   VDL         LV EVN                   I                               A   FESER..GL  N   HTMEFKNSVHTTGVDIPGE LRYAWEVARG.....................
1EYZ265   VEL         I  EVS                   A                               G   FVCGD..EV FS   PRPHDTGMVTLISQDLSEF LHVRAFLGLPVGGIRQYGPAASAVILPQLTS
1KEE283   V           IV EMN                                                   N QFAVNPKNGRL  I   PRVSRSSALASKATGFPIAKVAAKLAVGYTLDELMNDITGGRTPASFEPSI
1Z2P273   ID          LV DVN                   L                               G  FIKENEQGNP  V   VFPSYGGKVDFDWFVEKVA CYTEVAKI.......................
                       TT1Z2P  
CDC123
     300 310
CDC123 DMIAASEGENLLEFAQKWQDLTNKSNE...........................................
3R5X  ......................................................................
1E4E  ......................................................................
4IWX  ......................................................................
3VPD  ......................................................................
1EYZ333  QNVTFDNVQNAVGADLQIRLFGKPEIDGSRRLGVALATAESVVDAIERAKHAAGQVKVQG..........
1KEE353  DYVVTKIPRFNFEKFAGANDRLTTQMKSVGEVMAIGRTQQESLQKALRGLEVGATGFDPKVSLDDPEALT
1Z2P  ......................................................................
1Z2P  
CDC123
CDC123 ................
3R5X  ................
1E4E  ................
4IWX  ................
3VPD  ................
1EYZ  ................
1KEE423  KIRRELKDAGADRIWY
1Z2P  ................
1Z2P  
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Figure S2: Structural alignment of sp-Cdc123 with enzymes from ATP-grasp superfamily 
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A- The sequence of Sp-Cdc123 was aligned to those of some ATP-Grasp enzymes according to the 
structural superimpositions. Secondary structure of Sp-Cdc123 is indicated at the top of the alignment. 
Secondary structure of Inositol 1,3,4-trisphosphate 5/6-Kinase (PDB ID code1Z2P; (Miller et al., 
2005)) is indicated at the bottom of the alignment. Color code for the secondary structure elements is 
the same as in Figures 2 and S4. Conserved residues are boxed and colored in red. Residues involved 
in ATP binding to Sp-Cdc123 are indicated with stars boxed in red. Residues involved in the binding 
of Sc-γDIII domain to Sp-Cdc123 are indicated with stars boxed in green. The figure was drawn with 
Espript (Gouet et al., 1999). Sequences are labeled according to the ID code of the corresponding PDB 
entry. 
B- Structural comparison of sp-Cdc123 with enzymes belonging to the ATP-grasp superfamily. 
Color code is as follows: in Cdc123, domain 1 is colored in blue and domain 2 is colored in yellow. In 
ATP-Grasp enzymes, domain N is colored in grey, the central domain is colored in blue and the C-
terminal domain is colored in yellow.  Divergent regions in Cdc123 and ATP-grasp are shown in 
green. Ligands are shown with sticks when available. The small and large loops overhanging ATP in 
ATP-Grasp are shown in orange. Regions specific to Cdc123 proteins are colored in green. ATP is 
shown in sticks. Secondary structures common to Cdc123 and ATP-grasp are labeled. The PDB code 
of each represented ATP-grasp structure is indicated on the right of the cartoon. 4IWX, RimK , (Zhao 
et al., 2013) rmsd of 3.6 Å over 156 Cα atoms (Z=8.3); 3R23, D-alanine-D-alanine ligase, rmsd of 3.2 
Å over 160 Cα atoms (Z=11.2); 3VPD, LysX, (Ouchi et al., 2013) rmsd of 3.7 Å over 160 Cα atoms 
(Z=9.6); 1E4E, D-alanyl-D-lactate ligase (Roper et al., 2000) rmsd of 3.6 Å over 169 Cα 
atoms (Z=9.7); 1KEE, carbamoyl phosphate synthetase (Miles et al., 2002) rmsd of 3.3 Å over 179 Cα 
atoms (Z=9.1); 1EYZ, Glycimanide ribonucleotide transformylase (Thoden et al., 2000) rmsd of 3.3 Å 
over 175 Cα atoms (Z=9.1); 1Z2P, Inositol 1,3,4-trisphosphate 5/6-Kinase (Miller et al., 2005) rmsd 
3.1 Å over 166 Cα atoms (Z=10.0). 
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Figure S3: Biochemical characterization of Cdc123 
A-Titration curve (upper panel) and binding isotherm (lower panel) of Sp-Cdc123 interaction with 
ATP-Mg2+ at 25°C. The Kd value derived from the curve is 67 ± 13 µM.  
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B-SDS-PAGE analysis of the purification of the Sp-Cdc123:Sc-γDIII complex. Lane 1: sample 
obtained after the affinity chromatography step. Lane 2: sample obtained after molecular sieving. 
C-Upper part: Overlay of elution profiles on molecular sieve (Superdex 200 HR 10/30) of Sc-Cdc123 
(green), Sc-Cdc123:Sc-γDIII complex (blue) and Sc-γDIII (orange). Lower part: SDS-PAGE analysis 
of elution profile of Sc-Cdc123:Sc-γDIII complex (blue curve in upper panel). The number of each 
fraction is indicated (one fraction was collected every minute, 0.4 mL/min flow rate). 
D-Titration curve (upper panel) and binding isotherm (lower panel) of Sc-Cdc123 interaction with Sc-
γDIII at 25°C. The Kd value derived from the curve is 2.5 ± 0.5 µM. 
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Figure S4: e/aIF2γDIII domain. 
A-Cartoon representation of the γDIII domain. Left part: aIF2γDIII domain from S. solfataricus (PDB 
ID Code 2AHO, (Yatime et al., 2006)) colored in light blue. Middle part: eIF2γDIII domain from S. 
cerevisae as determined in this study, colored in orange. Right part: Superimposition of both structures 
(rmsd=0.69Å over 79 Cα atoms). Secondary structures are labeled according to (Yatime et al., 2006). 
B-Alignment of e/aIF2-γDIII domains sequences. 10 sequences of eukaryotic eIF2γ and 9 sequences 
of archaeal aIF2γ (framed in blue) were aligned using ClustalW (Larkin et al., 2007). The figure was 
drawn with Espript (Gouet et al., 1999). When the percentage of identity is higher that 70%, residues 
are colored in red and framed in blue. In case of strict identity, residues are in white on a red 
background. Residues involved in the binding of Sc-γDIII domain to Sp-Cdc123 are indicated with 
stars boxed in green. Secondary structures of Sc-γDIII are indicated at the top of the alignment and 
those of Ss-aIF2-γDIII are indicated at the bottom. 
C- Binding assay of Sc-γDIII to Sp-Cdc123. 
The pull-down binding assay is described in the Material and Methods section. An equal aliquot of 
each step of the batch purification (Talon affinity resin) was loaded onto a 12% polyacrylamide SDS 
gel. Stars indicate the position of Sc-γDIII. 
Lane 1: soluble fraction of the crude extract 
Lane 2: flow-through fraction of the batch purification 
Lane 3: elution fraction of the batch purification 
M:molecular weight marker (97, 67, 43, 30, 20, 14 kDa; GE Healthcare) 
The views show that R504 and W509 mutants have lost some ability to bind Sp-Cdc123. 
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Figure S5: Binding of ATP in Sp-cdc123:Sc-eIF2γDIII complex 
A- View of the 2.9 Å ‘2mFo-DFc’ map of the Sp-cdc123:Sc-eIF2γDIII complex contoured at 1.0 
standard deviation. Magnesium ion and water molecules are shown as green and red spheres, 
respectively. The view shows the coordination sphere of the magnesium ion involving the three highly 
conserved residues D227, D239 and N241 (Figure S1). B- Superimposition of the Sp-
Cdc1223∆C:ADP structure on that of  Sp-cdc123:Sc-eIF2γDIII:ATP-Mg2+ structure. Residues of Sp-
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cdc123:Sc-eIF2γDIII:ATP-Mg2+ are colored in yellow and those of Sp-Cdc1223∆C:ADP are in cyan. 
Magnesium ion is shown as a green sphere and water molecules as yellow and cyan spheres. 
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Figure S6: Interaction of Sc-Cdc123 with eIF2 subunits and role of the C-terminal domain 
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A- Interaction of Cdc123 with eIF2α and γ subunits. 
Immunoprecipitates of Cdc123 and Cdc123-DIN were analyzed for co-precipitation of eIF2α and 
eIF2γ in  yeast strains that express a myc-tagged version of eIF2α and overexpresses from the TEF2 
promoter a flag-tagged version of Cdc123 (WT) (W14185) or Cdc123-DIN (DIN) (W14186). A strain 
that expresses a myc-tagged version of eIF2α but lacks a flag-tagged version of Cdc123 (-) (W9876) 
was included as a negative control. Protein levels were determined by Western analysis in yeast whole 
cell extracts (WCE). Immunoprecipitates (IP) of Cdc123-flag and Cdc123-DIN-flag were prepared 
and analyzed for the presence of eIF2α and eIF2γ (Co-IP). For precipitation and detection of Cdc123-
flag and Cdc123-DIN-flag the mouse monoclonal antibody M2 was used. eIF2α-myc and eIF2γ were 
detected by the mouse monoclonal antibody 9E10 and a rabbit antiserum to eIF2γ (Perzlmaier et al., 
2013), respectively. Relative to eIF2γ, much lower amounts of eIF2α co-precipitated with Cdc123. 
The DIN mutation of Cdc123 reduced the interaction of Cdc123 with eIF2γ, but had little or no effect 
on the interaction of Cdc123 with eIF2α. 
B- Role of the L1 loop of eIF2γ in the interaction of eIF2γ with Cdc123, eIF2α and eIF2β. 
A yeast-two-hybrid assay was used to evaluate the consequences of deleting part of the L1 loop of 
eIF2γ (Sc-eIF2γ/Gcd11 aa325-331) on the ability of eIF2γ to associate with Cdc123 and eIF2 subunits. 
The reporter strain W276 was co-transformed with the indicated combination of a pEG202-derived 
DNA binding domain (BD) plasmid (BD-Cdc123: pWS1463; BD-eIF2α: pWS1537; BD-eIF2β: 
pWS1535) and a pJG4-5-derived transcriptional activation domain (AD) plasmid (AD -: pJG4-5; AD-
eF2γ: pWS1513; AD-eIF2γ ΔL1 loop: pED002). The yeast-two-hybrid vector plasmids pEG202 and 
pJG4-5 have been described (Ausubel et al., 2005). Yeast colonies were overlayed with an X-gal top 
agar to visualize β-galactosidase reporter activation. The L1 loop deletion of eIF2γ reduced the 
interaction of eIF2γ with Cdc123 and prevented any interaction with eIF2α, but had little or no effect 
on the interaction with eIF2β. 
C- Role of the C-terminal domain of Cdc123 
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A C-terminal truncation mutant of Cdc123 (Cdc123(1-291) lacking 69 amino acids from the C-
terminus) was analyzed for its ability to interact with eIF2γ and support cell viability. 
Left upper panel- Yeast-two-hybrid analysis of the Cdc123-eIF2γ interaction. The reporter strain 
W276 was co-transformed with the indicated combination of a pEG202-derived DNA binding domain 
(BD) plasmid (BD-Cdc123: pWS1463; BD-Cdc123(1-291): pWS3801) and a pJG4-5-derived 
transcriptional activation domain (AD) plasmid (AD -: pJG4-5; AD-eF2γ: pWS1513). The yeast-two-
hybrid vector plasmids pEG202 and pJG4-5 have been described (Ausubel et al., 2005). Yeast 
colonies were overlayed with an X-gal top agar to visualize β-galactosidase reporter activation. 
Left lower panel- Co-immunoprecipitation analysis of the Cdc123-eIF2γ interaction. Strains 
expressing flag-tagged versions of Cdc123 (WT; W14236) or Cdc123(1-291) (ΔC; W14237) from the 
regulable GAL1 promoter were used for preparation of whole cell extracts (WCE), anti-flag 
immunoprecipitation (IP) and analysis of co-precipitation (Co-IP) of eIF2γ. A strain lacking a flag-
tagged version of Cdc123 (-; W9878) was used as a negative control. Cdc123-flag, Cdc123(1-291)-
flag and eIF2γ protein levels were detected by Western analysis of whole cell extracts (WCE). 
Cdc123-flag and Cdc123(1-291)-flag were immunoprecipitated (IP) and detected with the mouse 
monoclonal flag antibody M2. The precipitates were analyzed for co-precipitation of eIF2γ (Co-IP) 
using a rabbit antiserum to eIF2γ (Perzlmaier et al., 2013). 
Right panels- Tetrade dissection analysis for evaluating the biological function of Cdc123(1-291). 
Diploid yeast cells heterozygote for a C-terminal HA3-fusion of either wild-type CDC123 (upper 
panel; W14233) or C-terminal truncation mutant CDC123(1-291) (lower panel; W2880) were 
sporulated and subjected to tetrad dissection. 
The C-terminal truncation of Cdc123 had no effect on the interaction of Cdc123 with eIF2γ, but 
disrupted the biological function of Cdc123. 
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  Supplemental Table 
 
 
 
 
Full-length cdc123a  
 
Full-length cdc123 a 
 
Full-length cdc123 
Se-met 
Data collection    
Crystallization 
Conditions 
 
22.5% PEG3350 
20mM (NH4)2C4H4O6 
+ATP-Mg2+ 
22.5% PEG3350 
20mM(NH4)2C4H4O6 
 
20%PEG3350 
0.1M NH4F 
 
Space group P212121 C222 C222 
Cell dimensions      
    a, b, c (Å) 87.69 100.19 129.68 87.17 208.07 87.45 86.42 295.6 86.00 
    a, b, γ  (°)  90 90 90 90 90 90 90 90 90 
Molecules in a.u 4 2 2 
Resolution (Å) 49.1-3.0 49.10-3.24 49.4-5.5 
Rsym  10.5 (135.0)b 4.8 (71.1) 7.6 (42.1) 
I/σI 13.55 (1.29) 19.68 (2.42) 23.01 (6.85) 
CC1/2 99.9 (61.2) 99.9 (81.3) 99.9 (97.3) 
Completeness (%) 99.9 (99.8) 96.8 (95.9) 99.8 (100) 
Redundancy 7.3 (7.4) 5.51 (5.50) 14.36 (14.88) 
    
sigAno   1.671 (0.943) 
Ano. Correlation (%)   57 (23) 
Table S1: Data collection statistics for Sp-cdc123 structure resolution  
aA single crystal was used for data collection.  
bValues in parentheses are for highest-resolution shell. 
 
 
 
 
Supplemental Experimental Procedures 
 
Protein expression and purification 
 
Sc-γDIII  
Sc-γDIII domain was purified from 1 liter of culture of BL21 Rosetta E. coli cells transformed 
with pET3a-Sc-γDIII. The pellet was resuspended in buffer A. After sonication and centrifugation, the 
extract was loaded onto an S-Sepharose column (16mm x 20cm; GE-Healthcare) equilibrated in buffer 
A. A gradient from 200 mM NaCl to 1 M NaCl was used for elution (300 mL at a flow rate of 2.5 
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mL/min). The recovered fractions were pooled, concentrated and loaded onto a Superdex 200 HR 
10/30 column equilibrated in buffer A. The purified protein was concentrated to 10 mg/mL. 
An N-terminally tagged version of Sc-γDIII domain was purified from BL21 Rosetta E. coli 
cells transformed with PWS3915 and induced with 0.2% rhamnose after overnight culture at 37°C. 
The same purification protocol as the one described above was used for the purification except that a 
first step of affinity chromatography was added. The resulting protein was used to perform titration 
experiments using isothermal calorimetry (ITC). 
Sc-Cdc123 
Plasmid pWS1389 allows expression of an N-terminally his-tagged version of Sc-Cdc123. 
The plasmid was transformed into BL21 Rosetta E. coli cells. Overexpression of Sc-Cdc123 was 
induced with 0.2% rhamnose after overnight culture at 37°C. After induction, the culture was 
continued for 4 hours at 18°C. The cells were resuspended in buffer B.  After sonication and 
centrifugation, the crude extract was loaded onto a column (4 mL) containing Talon affinity resin 
(Clontech) equilibrated in buffer B. Sc-Cdc123 was eluted with buffer B containing 125 mM 
imidazole. After dialysis against buffer C (10 mM HEPES pH 7.5, 100 mM NaCl, 3 mM 2-
mercaptoethanol, 0.1 mM PMSF, 0.1 mM benzamidine), the protein was loaded onto a Q-Sepharose 
column (0.8 mm x 3 cm; GE-Healthcare) equilibrated in buffer C. A gradient from 100 mM NaCl to 
600 mM NaCl was used for elution (60 mL at a flow rate of 2mL/min). The recovered protein was 
finally concentrated and loaded onto a Superdex 200 column (HR 10/30; GE Healthcare) equilibrated 
in buffer A. Fractions containing Sp-Cdc123:Sc-γDIII were pooled and concentrated to 10 mg/mL. 
SAXS data collection 
SAXS experiments were conducted on beamline SWING at the SOLEIL Synchrotron (λ = 
1.033 Å). The Aviex charge-coupled device detector was positioned at a distance of 2076 mm from 
the sample, with the direct beam off-centered. Data were collected in the Q-range 0.008–0.5 Å−1 (Q = 
4πsinθ/λ, 2θ is the scattering angle). All solutions were circulated in a thermostated (15 °C) quartz 
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  capillary with a diameter of 1.5 mm and a wall thickness of 10 µm, positioned within a vacuum 
chamber.  
For data collection purified complex Sp-Cdc123-γDIII  (c.a 20 nanomoles in 100-200 µl) was 
injected on a size-exclusion column (Agilent© BioSEC 3-300) using an Agilent© High Performance 
Liquid Chromatography system and eluted directly into the SAXS flow-through capillary cell at a 
flow rate of 0.2 mL/min. The elution buffer was 10 mM Hepes pH 7.5, 500 mM NaCl. SAXS data 
were collected online, with a frame duration of 1.5 s and a dead time between frames of 1.0 s. A large 
number of frames were collected during the first minutes of the elution and averaged to account for 
buffer scattering, which was subsequently subtracted from the signal during elution of the protein 
complex. Selected curves corresponding to the main elution peak were averaged on the basis of 
identical shapes (David and Perez, 2009). Data reduction to absolute units, frame averaging and 
subtraction, were performed using FOXTROT (http://www.synchrotron-
soleil.fr/Recherche/LignesLumiere/SWING). All subsequent data processing, analysis, and modeling 
steps were carried out with PRIMUS and other programs of the ATSAS suite (Konarev et al., 2006). 
Scattered intensity curves were calculated from the atomic coordinates of the crystallographic 
structures using CRYSOL (Svergun et al., 1995) with 50 harmonics. This program was also used to fit 
the calculated curve to the experimental one, by adjusting the excluded volume, the averaged atomic 
radius and the contrast of the hydratation layer surrounding the particle in solution. 
 
Pull-Down assays 
A 15 mL culture of wt-Sc-γDIII or mutant Sc-γDIII (E460A, R504A, W509A) was mixed to a 
15 mL culture of N-terminally tagged version of Sp-Cdc123, centrifugated and resuspended in 1 mL 
of buffer B. After sonication, the insoluble fraction was removed by centrifugation. The crude extract 
was then mixed with 200 µL of metal affinity resin (Talon, Clontech) to perform batch purification. 
After several rounds of beads washing, the retained complex was eluted from the resin with buffer B 
supplemented with 125 mM imidazole. A fixed volume aliquot of each step of the batch purification 
was loaded onto a 12% polyacrylamide SDS gel (Figure S4).  
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ITC 
Binding of γDIII 
Before ITC measurements, proteins were dialyzed against buffer B. Titrations curves were 
obtained using a MicroCal200 apparatus (Malvern). Sc-Cdc123 (250 µL, 20 µM) was titrated by 20 
injections (4 µL) of Sc-γDIII at a concentration of 150 µM. A typical titration curve is shown in  
Figure S3C. The deduced dissociation constant for the Sc-γDIII:Sc-Cdc123 complex was 2.5 ± 0.5 
µM. 
Binding of ATP 
Before ITC measurements proteins were dialyzed against buffer A supplemented with 5 mM 
MgCl2. Titrations curves were obtained using a MicroCal200 apparatus (Malvern). 250 µL of Sp-
Cdc123 or of Sp-Cdc123-γDIII complex, (125 µM) was titrated by 20 injections (4 µL) of ATP at a 
concentration of 1.25 mM. A typical titration curve is shown in  Figure S3A. The deduced dissociation 
constant were similar for the Sc-Cdc123:ATP-Mg2+ complex (67 ± 13 µM) and for the Sc-Cdc123-
γDIII:ATP-Mg2+ complex (57 ± 7 µM). Reported results are mean ± s.d. from at least two independent 
experiments.  
 
Yeast methods 
For growth, transformation, mating, sporulation, and tetrad dissection of budding yeast cells, 
standard protocols were followed (Ausubel et al., 2005). Yeast strains used in this study are isogenic 
derivatives of W303 and listed below. Cells were grown in YEP complex medium containing adenine 
(100 mg/L), tryptophan (200 mg/L), KH2PO4 (10 mM), and glucose (2%) or raffinose (2%). To induce 
expression from the GAL1 promoter, 2% galactose was added to YEP complex medium containing 
raffinose.  
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strain relevant genotype figure	  
W276 MATα  his3  trp1 ura3::lexA-op-lacZ-URA3  leu2::lexA-op-LEU2 S9, S11	  
W2880 MATa/α  CDC123/CDC123(1-291)-HA3-HIS3MX6 S11	  
W7743 MATα  CDC123  trp1::pTEF2-3xFLAG-GCD11-tCYC1-TRP1  
ura3::pTEF2-SUI2-tCYC1-URA3 
5B	  
W7745 MATα  cdc123-delta::kanMX4  trp1::pTEF2-3xFLAG-GCD11-tCYC1-
TRP1   ura3::pTEF2-SUI2-tCYC1-URA3 
5B	  
W9876 MATa/α  SUI2/SUI2-MYC13-HIS3MX6 S10	  
W9878 MATα  ura3 S11	  
W13930 MATα  cdc123-delta::kanMX4    trp1::pTEF2-3xFLAG-GCD11-tCYC1-
TRP1   ura3::pTEF2-SUI2-tCYC1-URA3  leu2::pCDC123-CDC123-
tCYC1-LEU2 
5B	  
W13931 MATα  cdc123-delta::kanMX4    trp1::pTEF2-3xFLAG-GCD11-tCYC1-
TRP1   ura3::pTEF2-SUI2-tCYC1-URA3  leu2::pCDC123-CDC123DIN-
tCYC1-LEU2 
5B	  
W13935 MATa/α  CDC123/cdc123-delta::kanMX4  pCDC123-CDC123D252A-
tCYC1-URA3 (ARS/CEN) 
5B	  
W13936 MATa/α  CDC123/cdc123-delta::kanMX4  pCDC123-CDC123DIN(266-
268)-tCYC1-URA3 (ARS/CEN) 
5B	  
W14145 MATa/α  CDC123/cdc123-delta::kanMX4  pCDC123-CDC123-tCYC1-
URA3 (ARS/CEN) 
5B	  
W14185 MATa/α  SUI2/SUI2-MYC13-HIS3MX6  ura3/ura3::pTEF2-CDC123-
FLAG3-tCYC1-URA3 
S10	  
W14186 MATa/α  SUI2/SUI2-MYC13-HIS3MX6  ura3/ura3::pTEF2-CDC123DIN-
FLAG3-tCYC1-URA3 
S10	  
W14233 MATa/α  CDC123/CDC123-HA3-HIS3MX6 S11	  
W14236 MATα  ura3::pGAL1-CDC123-FLAG3-tCYC1-URA3 S11	  
W14237 MATα  ura3::pGAL1-CDC123(1-291)-FLAG3-tCYC1-URA3 S11	  
W14238 MATα  cdc123-delta::kanMX4    trp1::pTEF2-3xFLAG-GCD11-tCYC1-
TRP1   ura3::pTEF2-SUI2-tCYC1-URA3  leu2::pCDC123-CDC123D252A-
tCYC1-LEU2 
5B 
Yeast strains 
DNA constructs and genetic manipulation 
Yeast plasmid constructs used in this study are derivatives of pRS vectors (Sikorski and 
Hieter, 1989), pEG202 or pJG4-5 (Ausubel et al., 2005) and are listed below. C-terminal epitope 
fusions of endogenous genes and the C-terminal truncation of CDC123 (CDC123(1-291)) were 
constructed by PCR-based epitope tagging (Longtine et al., 1998). Site-directed mutagenesis (Quick-
change; Stratagene) was used to replace the D266, I267, N268, and D252 codons of CDC123 by 
alanine codons. 
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  name description vector figure 
pED002 pGAL-NLS-AD-HA-GCD11-delta L1 loop(delta325-331) pJG4-5 S9 
pJG4-5 pGAL-NLS-AD-HA-MCS, TRP1, 2µ  S9, S11 
pWS1378 pCDC123-CDC123-tCYC1, ARS/CEN pRS416 5B 
pWS1463 pADH-lexA-CDC123 pEG202 S9, S11 
pWS1513 pGAL-NLS-AD-HA-GCD11 pJG4-5 S9, S11 
pWS1535 pADH-lexA-SUI3 pEG202 S9 
pWS1537 pADH-lexA-SUI2 pEG202 S9 
pWS1846 pCDC123-CDC123-tCYC1 pRS305 5B 
pWS3801 pADH-lexA-CDC123(1-291) pEG202 S11 
pWS4398 pCDC123-CDC123D252A-tCYC1, ARS/CEN pRS416 5B 
pWS4399 pCDC123-CDC123D266A/I267A/N268A-tCYC1, ARS/CEN pRS416 5B 
pWS4465 pCDC123-CDC123D266A/I267A/N268A-tCYC1 pRS305 5B 
pWS4488 pTEF2-CDC123-FLAG3-tCYC1 pRS306 S10 
pWS4501 pTEF2-CDC123D266A/I267A/N268A -FLAG3-tCYC1 pRS306 S10 
pWS4671 pCDC123-CDC123D252A-tCYC1 pRS305 5B 
pWS4677 pGAL1-CDC123-FLAG3-tCYC1 pRS306 S11 
pWS4678 pGAL1-CDC123(1-291)-FLAG3-tCYC1 pRS306 S11 
Yeast plasmids 
 
Yeast-Two-Hybrid assay 
The Y2H reporter strain W276 was co-transformated with pEG202 and pJG4-5 derivatives. 
Transformants were spotted on synthetic complete solid medium lacking histidine and tryptophan and 
containing saccharose (1%) and galactose (2%). Plates were incubated over night at 30°C. β-
galactosidase activity was visualized by overlaying the yeast colonies with an X-gal top agar 
containing sodium phosphate buffer (0.5 M, pH 7.0), DMFA (6%), X-Gal (0.2 mg/ml), SDS (0.1%), 
and Bacto agar (0.5%). Coloration was documented after incubation over night at 30°C.  
 
Yeast cell extracts, immunoprecipitation and Western analysis 
Whole cell protein extracts and immunoprecipitations were made as described (Arnold et al., 
2015; Perzlmaier et al., 2013). SDS-PAGE and Western analysis were done essentially as described 
(Schwab et al., 2001). Mouse monoclonal antibodies M2 (Sigma-Aldrich) and 9E10 were used for 
detection of FLAG-tagged and MYC-tagged proteins, respectively. eIF2α (Sui2), eIF2γ (Gcd11), and 
Cdc123 were detected using a polyclonal rabbit antiserum (Sui2) or affinity-purified polyclonal rabbit 
antisera (Gcd11, Cdc123) (Perzlmaier et al., 2013). Detection of immunoblots was done using IRDye 
secondary antibodies and an Odyssey infrared imaging system (LI-COR Biosciences). 
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